Bonesupport Holding ABBOEUF 81 3-Year ROIIC % is 55.81 as of Dec. 2025, which is 43% above its 10-year median of 39.13. GuruFocus rates BOEUF with a GF Score™ of 81/100 and a GF Value™ of $42.37 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 799 Medical Devices & Instruments companies, Bonesupport Holding AB ranks better than 84.11% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Bonesupport Holding AB's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was 55.81%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Bonesupport Holding AB's 3-Year ROIIC % or its related term are showing as below:
BOEUF's 3-Year ROIIC % is ranked better than 84.11% of 799
companies
in the Medical Devices & Instruments industry
Industry Median: 1.67
vs BOEUF: 55.81
Bonesupport Holding AB (OTCPK:BOEUF) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Bonesupport Holding AB 3-Year ROIIC % Related Terms
Bonesupport Holding AB 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Bonesupport Holding AB's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOEUF vs ISRG, BDX, MDLN: 3-Year ROIIC % Comparison
For the Medical Instruments & Supplies subindustry, Bonesupport Holding AB's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bonesupport Holding AB 3-Year ROIIC % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Bonesupport Holding AB's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Bonesupport Holding AB's 3-Year ROIIC % falls into.
Bonesupport Holding AB's 3-Year ROIIC % for the quarter that ended in Dec. 2025 is calculated as:
3-Year ROIIC %
=
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( 21.279525 (Dec. 2025) - -6.514 (Dec. 2022) )
/
( 66.924 (Dec. 2025) - 14.112 (Dec. 2022) )
=
27.793525
/
52.812
=
52.63%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Bonesupport Holding AB (BOEUF) has a 3-Year ROIIC % of 55.81 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Bonesupport Holding AB and its competitors. This is 43% above median its historical median of 39.13. According to the industry distribution chart, Bonesupport Holding AB ranks #127 out of 799 companies in the Medical Devices & Instruments industry, placing it in the top 15.9%.
Is Bonesupport Holding AB's 3-Year ROIIC % too high?
Bonesupport Holding AB's current 3-Year ROIIC % of 55.81 is 43% above median its 10-year median of 39.13. The Medical Devices & Instruments industry median 3-Year ROIIC % is 1.67. Bonesupport Holding AB's value of 55.81 is 3241.9% above this industry median. Based on the distribution chart, Bonesupport Holding AB ranks #127 out of 799 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Bonesupport Holding AB has a GF Score™ of 81/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bonesupport Holding AB's 3-Year ROIIC % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Bonesupport Holding AB ranks #127 out of 799 companies for 3-Year ROIIC %. This places Bonesupport Holding AB in the top 16% of its industry — outperforming the majority of peers. The industry median 3-Year ROIIC % is 1.67. Bonesupport Holding AB's value of 55.81 is 3241.9% above this benchmark. While the company's 10-year median is 39.13 vs. the industry median of 1.67, Bonesupport Holding AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Medical Devices & Instruments company?
The median 3-Year ROIIC % among Medical Devices & Instruments companies is 1.67, based on 799 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bonesupport Holding AB's current 3-Year ROIIC % of 55.81 is 3241.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Bonesupport Holding AB and its competitors. For the Medical Devices & Instruments industry, the median 3-Year ROIIC % is 1.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bonesupport Holding AB's current 3-Year ROIIC % is 55.81, which is 43% above median its own 10-year median of 39.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bonesupport Holding AB stock overvalued right now?
Based on GuruFocus' analysis, Bonesupport Holding AB (BOEUF) is currently considered Significantly Undervalued. The stock's GF Value™ is $42.37, compared to a current price of $21.40 — trading 49.5% below its estimated fair value. The current 3-Year ROIIC % is 55.81, which is 43% above median its 10-year median of 39.13 and 3241.9% above the Medical Devices & Instruments industry median of 1.67. Bonesupport Holding AB's overall GF Score™ is 81/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Bonesupport Holding AB (BOEUF), the current 3-Year ROIIC % is 55.81 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bonesupport Holding AB (BOEUF) Overvalued in 2026?
Based on GuruFocus' analysis, Bonesupport Holding AB stock appears to be undervalued.
The current stock price of $21.40 is trading 49.5% below its estimated GF Value™ of $42.37.
GuruFocus considers Bonesupport Holding AB to be Significantly Undervalued.
Key valuation signals for BOEUF:
3-Year ROIIC %: 55.81 (43% above median its 10-year median of 39.13)
GF Value™: $42.37 vs. price of $21.40 (49.5% below fair value)
Industry Position: 3241.9% above the Medical Devices & Instruments median (#127 of 799)
No single metric tells the full story. See the BOEUF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bonesupport Holding AB is a fast-growing ortho-biologics company that focuses on the treatment of bone disorders. The Company develops and commercializes injectable bio-ceramic bone graft substitutes based on its CERAMENT platform, which remodels to bone and can release pharmaceuticals to promote healing. The products of the company focus on trauma, revision arthroplasty (replacement of joint prostheses), chronic osteomyelitis (bone infection), and foot and ankle surgery. The Group manages and monitors operations in two operating segments: United States and Europe & Rest of the World (EUROW).
81GF Score
Get the complete analysis for BOEUF
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOEUF has been successfully added to your 
